• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨重塑的表观遗传调控及其在原发性骨质疏松症发病机制中的作用。

Epigenetic regulation of bone remodeling and its role in the pathogenesis of primary osteoporosis.

作者信息

Yalaev B I, Khusainova R I

机构信息

Institute of Biochemistry and Genetics - Subdivision of the Ufa Federal Research Center of the Russian Academy of Sciences, Ufa, Russia Saint Petersburg State University, St. Petersburg, Russia.

Institute of Biochemistry and Genetics - Subdivision of the Ufa Federal Research Center of the Russian Academy of Sciences, Ufa, Russia Saint Petersburg State University, St. Petersburg, Russia Ufa University of Science and Technology, Ufa, Russia.

出版信息

Vavilovskii Zhurnal Genet Selektsii. 2023 Jul;27(4):401-410. doi: 10.18699/VJGB-23-48.

DOI:10.18699/VJGB-23-48
PMID:37465189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10350859/
Abstract

Discovery of molecular mechanisms of primary osteoporosis development is fundamental to understand the pathogenesis of musculoskeletal diseases in general and for identifying key links in the genetic and epigenetic regulation of bone remodelling genes. The number of identified molecular genetic markers for osteoporosis is increasing but there is a need to describe their functional interactions. These interactions have been determined to be associated with the control of expression of a number of transcription factors and the differentiation of mesenchymal stem cells through the pathway of osteoblastogenesis or adipogenesis, and monocytic precursors through the pathway of osteoclastogenesis. The results of epigenetic studies have significantly increased the understanding of the role of post-translational modifications of histones, DNA methylation and RNA interference in the osteoporosis pathogenesis and in bone remodelling. However, the knowledge should be systematised and generalised according to the results of research on the role of epigenetic modifiers in the development of osteoporosis, and the influence of each epigenetic mechanism on the individual links of bone remodelling during ontogenesis of humans in general, including the elderly, should be described. Understanding which mechanisms and systems are involved in the development of this nosology is of interest for the development of targeted therapies, as the possibility of using microRNAs to regulate genes is now being considered. Systematisation of these data is important to investigate the differences in epigenetic marker arrays by race and ethnicity. The review article analyses references to relevant reviews and original articles, classifies information on current advances in the study of epigenetic mechanisms in osteoporosis and reviews the results of studies of epigenetic mechanisms on individual links of bone remodelling.

摘要

发现原发性骨质疏松症发展的分子机制对于理解一般肌肉骨骼疾病的发病机制以及确定骨重塑基因的遗传和表观遗传调控中的关键环节至关重要。已鉴定出的骨质疏松症分子遗传标记数量在不断增加,但需要描述它们的功能相互作用。这些相互作用已被确定与多种转录因子的表达控制以及间充质干细胞通过成骨细胞生成途径或脂肪生成途径的分化,以及单核细胞前体通过破骨细胞生成途径的分化有关。表观遗传学研究结果显著增进了对组蛋白翻译后修饰、DNA甲基化和RNA干扰在骨质疏松症发病机制及骨重塑中的作用的理解。然而,应根据关于表观遗传修饰剂在骨质疏松症发展中的作用的研究结果进行系统化和概括,并应描述每种表观遗传机制对一般人类个体发育过程中骨重塑各个环节的影响,包括老年人。了解哪些机制和系统参与了这种疾病的发展对于靶向治疗的开发很有意义,因为现在正在考虑使用微小RNA来调节基因的可能性。对这些数据进行系统化对于按种族和民族研究表观遗传标记阵列的差异很重要。这篇综述文章分析了相关综述和原始文章的参考文献,对骨质疏松症表观遗传机制研究的当前进展信息进行了分类,并综述了表观遗传机制在骨重塑各个环节的研究结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bf3/10350859/e06dbe1b9648/VJGB-27-2348-Tab2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bf3/10350859/7081d112d9c7/VJGB-27-2348-Tab1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bf3/10350859/e06dbe1b9648/VJGB-27-2348-Tab2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bf3/10350859/7081d112d9c7/VJGB-27-2348-Tab1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bf3/10350859/e06dbe1b9648/VJGB-27-2348-Tab2.jpg

相似文献

1
Epigenetic regulation of bone remodeling and its role in the pathogenesis of primary osteoporosis.骨重塑的表观遗传调控及其在原发性骨质疏松症发病机制中的作用。
Vavilovskii Zhurnal Genet Selektsii. 2023 Jul;27(4):401-410. doi: 10.18699/VJGB-23-48.
2
[Epigenetic Aspects of Osteoporosis].[骨质疏松症的表观遗传学方面]
Vestn Ross Akad Med Nauk. 2015(5):541-8. doi: 10.15690/vramn.v70.i5.1440.
3
Epigenetic Mechanisms in Bone Biology and Osteoporosis: Can They Drive Therapeutic Choices?骨生物学和骨质疏松症中的表观遗传机制:它们能推动治疗选择吗?
Int J Mol Sci. 2016 Aug 12;17(8):1329. doi: 10.3390/ijms17081329.
4
Epigenomics in stress tolerance of plants under the climate change.植物在气候变化下的应激耐受中的表观基因组学。
Mol Biol Rep. 2023 Jul;50(7):6201-6216. doi: 10.1007/s11033-023-08539-6. Epub 2023 Jun 9.
5
Epigenetic Regulation of Skeletal Tissue Integrity and Osteoporosis Development.骨组织完整性和骨质疏松症发病的表观遗传调控
Int J Mol Sci. 2020 Jul 12;21(14):4923. doi: 10.3390/ijms21144923.
6
The effects of epigenetic modifications on bone remodeling in age-related osteoporosis.表观遗传修饰对与年龄相关的骨质疏松症中骨重塑的影响。
Connect Tissue Res. 2023 Mar;64(2):105-116. doi: 10.1080/03008207.2022.2120392. Epub 2022 Oct 21.
7
Epigenetic mechanisms in bone.骨组织中的表观遗传学机制。
Clin Chem Lab Med. 2014 May;52(5):589-608. doi: 10.1515/cclm-2013-0770.
8
Epigenetic landscape in PPARγ2 in the enhancement of adipogenesis of mouse osteoporotic bone marrow stromal cell.过氧化物酶体增殖物激活受体γ2(PPARγ2)的表观遗传景观在小鼠骨质疏松性骨髓基质细胞脂肪生成增强中的作用
Biochim Biophys Acta. 2015 Nov;1852(11):2504-16. doi: 10.1016/j.bbadis.2015.08.020. Epub 2015 Aug 28.
9
Epigenetics of bone diseases.骨疾病的表观遗传学。
Joint Bone Spine. 2018 Dec;85(6):701-707. doi: 10.1016/j.jbspin.2017.12.003. Epub 2017 Dec 12.
10
PPARγ forms a bridge between DNA methylation and histone acetylation at the C/EBPα gene promoter to regulate the balance between osteogenesis and adipogenesis of bone marrow stromal cells.过氧化物酶体增殖物激活受体 γ(PPARγ)在 C/EBPα 基因启动子处连接 DNA 甲基化和组蛋白乙酰化,以调节骨髓基质细胞中成骨与成脂的平衡。
FEBS J. 2013 Nov;280(22):5801-14. doi: 10.1111/febs.12500. Epub 2013 Sep 13.

引用本文的文献

1
Addressing osteoblast senescence: Molecular pathways and the frontier of anti-ageing treatments.应对成骨细胞衰老:分子途径与抗衰老治疗前沿
Clin Transl Med. 2025 Jul;15(7):e70417. doi: 10.1002/ctm2.70417.
2
The Role of microRNA in the Regulation of Differentiation and the Functionality of Osteoblasts, Osteoclasts, and Their Precursors in Osteoporosis.微小RNA在骨质疏松症中对成骨细胞、破骨细胞及其前体细胞分化和功能调控中的作用
Noncoding RNA. 2025 Feb 8;11(1):14. doi: 10.3390/ncrna11010014.
3
Hypomethylation of the Gene Is a New Potential Biomarker of Primary Osteoporosis in Men and Women.
基因低甲基化是男性和女性原发性骨质疏松症的一个新的潜在生物标志物。
Int J Mol Sci. 2024 Jul 3;25(13):7312. doi: 10.3390/ijms25137312.